News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 5, 2011

Guidelines for the Management of Menorrhagia

Author(s)Mahdy El-Mazzahy, MD

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Using a self-collected vaginal fluid test for endometrial cancer detection

Using a self-collected vaginal fluid test for endometrial cancer detection

ByElle Kielar Grevstad, PhD

June 22nd 2026

Systematic review reaffirms HPV vaccine safety, supports single-dose regimen | Image credit: Stock.adobe.com

Systematic review reaffirms HPV vaccine safety, supports single-dose regimen potential

ByJoshua Fitch, Senior Editor

May 5th 2026

Previewing ACOG's 75th Annual Clinical & Scientific Meeting

Previewing ACOG's 75th Annual Clinical & Scientific Meeting

ByJoshua Fitch, Senior Editor

May 1st 2026

Utepreva launches FDA-cleared endometrial sampler to support endometrial cancer detection | Image credit: Contemporary OB/GYN

Utepreva launches FDA-cleared endometrial sampler to support endometrial cancer detection

ByJoshua Fitch, Senior Editor

April 22nd 2026

FAQ: Breaking down ACOG's updated guidance for evaluating postmenopausal bleeding | Image credit: Stock.adobe.com

FAQ: Breaking down ACOG's updated guidance for evaluating postmenopausal bleeding

ByJoshua Fitch, Senior Editor

April 20th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

Natural Cycles receives FDA clearance for AI-powered fertility algorithm

FDA grants 510(k) clearance to Roche's cobas BV/CV assay

Late preterm hypoglycemia not tied to neurodevelopment at age 6

CMS' obstetric G-codes draw concern, HIV screening recommendation strengthened, Roche's BV/CV assay clearance